A Von Eckardstein, JR Nofer… - … , thrombosis, and vascular …, 2001 - Am Heart Assoc
High density lipoprotein (HDL) cholesterol is an important risk factor for coronary heart disease, and HDL exerts various potentially antiatherogenic properties, including the …
HDL is a major atheroprotective factor, but the mechanisms underlying this effect are still obscure. HDL binding to scavenger receptor-BI has been shown to activate eNOS, although …
JR Nofer, B Kehrel, M Fobker, B Levkau, G Assmann… - Atherosclerosis, 2002 - Elsevier
The inverse correlation between serum levels of high density lipoprotein (HDL) cholesterol and the risk of coronary heart disease, the protection of susceptible animals from …
JR Nofer, B Levkau, I Wolinska, R Junker… - Journal of Biological …, 2001 - ASBMB
Apoptotic cell death following injury of vascular endothelium is assumed to play an important role in the pathogenesis of atherosclerosis. In this report, we demonstrate that high density …
G Assmann, JR Nofer - Annual review of medicine, 2003 - annualreviews.org
Observational studies provide overwhelming evidence that a low high-density lipoprotein (HDL)–cholesterol level increases the risk of coronary events, both in healthy subjects and …
T Kimura, K Sato, E Malchinkhuu… - … , and vascular biology, 2003 - Am Heart Assoc
Objective—Plasma high-density lipoprotein (HDL) level is inversely correlated with the risk of atherosclerosis. However, the cellular mechanism by which HDL exerts antiatherogenic …
F Okajima - Biochimica et Biophysica Acta (BBA)-Molecular and …, 2002 - Elsevier
Sphingosine 1-phosphate (S1P) concentration in plasma and serum has been estimated to be within 200–900 nM. Among plasma and serum components, S1P is concentrated in …
BJ O'Connell, J Genest Jr - Circulation, 2001 - Am Heart Assoc
Elevated plasma levels of HDL cholesterol or apolipoprotein AI, the major protein moiety of HDL particles, are protective against coronary artery disease. HDL particles remove …
S Rodriguez-Cuenca, V Pellegrinelli, M Campbell… - Progress in lipid …, 2017 - Elsevier
Sphingolipids in general and ceramides in particular, contribute to pathophysiological mechanisms by modifying signalling and metabolic pathways. Here, we present the …